Fidelity Investments’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-2,446,390
| Closed | -$9.59M | – | 5775 |
|
2023
Q3 | $9.59M | Buy |
2,446,390
+2,319,965
| +1,835% | +$9.09M | ﹤0.01% | 1838 |
|
2023
Q2 | $411K | Sell |
126,425
-683,429
| -84% | -$2.22M | ﹤0.01% | 2720 |
|
2023
Q1 | $2.93M | Sell |
809,854
-11,564
| -1% | -$41.8K | ﹤0.01% | 2263 |
|
2022
Q4 | $26.4M | Buy |
821,418
+11,465
| +1% | +$369K | ﹤0.01% | 1503 |
|
2022
Q3 | $33.9M | Buy |
809,953
+668
| +0.1% | +$27.9K | ﹤0.01% | 1401 |
|
2022
Q2 | $34.2M | Buy |
809,285
+406,961
| +101% | +$17.2M | ﹤0.01% | 1427 |
|
2022
Q1 | $27.3M | Buy |
402,324
+1,374
| +0.3% | +$93.2K | ﹤0.01% | 1647 |
|
2021
Q4 | $48.7M | Buy |
400,950
+463
| +0.1% | +$56.2K | ﹤0.01% | 1431 |
|
2021
Q3 | $56.4M | Buy |
400,487
+183
| +0% | +$25.8K | ﹤0.01% | 1362 |
|
2021
Q2 | $110M | Buy |
400,304
+292
| +0.1% | +$80.2K | 0.01% | 1087 |
|
2021
Q1 | $85.6M | Buy |
400,012
+59,844
| +18% | +$12.8M | 0.01% | 1137 |
|
2020
Q4 | $82.3M | Buy |
340,168
+90,119
| +36% | +$21.8M | 0.01% | 1120 |
|
2020
Q3 | $26.4M | Buy |
250,049
+22,488
| +10% | +$2.37M | ﹤0.01% | 1450 |
|
2020
Q2 | $22.3M | Buy |
227,561
+66,518
| +41% | +$6.52M | ﹤0.01% | 1505 |
|
2020
Q1 | $12.1M | Sell |
161,043
-1,078
| -0.7% | -$81K | ﹤0.01% | 1633 |
|
2019
Q4 | $13.2M | Sell |
162,121
-3,377
| -2% | -$274K | ﹤0.01% | 1748 |
|
2019
Q3 | $20.2M | Sell |
165,498
-2,885
| -2% | -$352K | ﹤0.01% | 1571 |
|
2019
Q2 | $30.2M | Buy |
168,383
+2,128
| +1% | +$382K | ﹤0.01% | 1447 |
|
2019
Q1 | $26.6M | Buy |
166,255
+955
| +0.6% | +$153K | ﹤0.01% | 1462 |
|
2018
Q4 | $43M | Buy |
165,300
+2,055
| +1% | +$535K | 0.01% | 1210 |
|
2018
Q3 | $38.6M | Sell |
163,245
-2,310
| -1% | -$546K | ﹤0.01% | 1394 |
|
2018
Q2 | $36.8M | Buy |
+165,555
| New | +$36.8M | ﹤0.01% | 1430 |
|